ArticleDiabetes care2021

Comparative Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults.

Elisabetta Patorno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.